{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-25-004324","form_type":"8-K","ticker":"NTHI","cik":"0001979414","company_name":"NEONC TECHNOLOGIES HOLDINGS, INC.","filed_at":"2025-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.617721+00:00","generated_at":"2026-05-19T18:47:02.282459+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"NeOnc Technologies appoints Josh Neman as Chief Clinical Officer","bullets":["Josh Neman appointed Chief Clinical Officer effective June 5, 2025; base salary $165,000/year.","Granted 200,000 RSUs: 1/3 vest Dec 30, 2025; 1/3 in 29 monthly installments; 1/3 performance-based.","Neman will continue his role as Associate Professor at USC Keck School of Medicine.","Neman also serves as CEO of Synaptical Inc. and CNSMENDER Consulting.","Employment term is 12 months with automatic annual renewal; at-will employment."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-25-004324","json":"https://secwatch.observer/filing/0001829126-25-004324.json","markdown":"https://secwatch.observer/filing/0001829126-25-004324.md","text":"https://secwatch.observer/filing/0001829126-25-004324.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1979414/000182912625004324/0001829126-25-004324-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1979414/000182912625004324/neonctechnologies_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T18:47:02.282459+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a029f66265","claim":"Josh Neman was appointed as Chief Clinical Officer at NEONC TECHNOLOGIES HOLDINGS, INC..","evidence_excerpt":"The Board of Directors (the “Board”) of the Company appointed Josh Neman as the Company’s Chief Clinical Officer, effective June 5, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1979414/000182912625004324/0001829126-25-004324-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Clinical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}